Financial Management Professionals, Inc. Repligen Corp Transaction History

Financial Management Professionals, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$138.42 - $180.31 $276 - $360	2 New	2 $0
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $481 - $768	3 New	3 $1,000
Q2 2022 Jul 12, 2022	SELL	$140.68 - $188.02 $562 - $752	-4 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$161.19 - $257.96 $161 - $257	-1 Reduced 20.0%	4 $1,000
Q4 2021 Jan 28, 2022	BUY	$247.59 - $304.47 $247 - $304	1 Added 25.0%	5 $1,000
Q2 2021 Aug 05, 2021	BUY	$165.87 - $220.95 $663 - $883	4 New	4 $1,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.